Legend Biotech Corp (LEGN)
45.42
-0.50
(-1.08%)
USD |
NASDAQ |
May 03, 16:00
45.42
0.00 (0.00%)
After-Hours: 18:57
Legend Biotech Price to Book Value: 6.602 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 6.674 |
| May 01, 2024 | 6.393 |
| April 30, 2024 | 6.358 |
| April 29, 2024 | 6.562 |
| April 26, 2024 | 6.585 |
| April 25, 2024 | 6.457 |
| April 24, 2024 | 6.566 |
| April 23, 2024 | 6.898 |
| April 22, 2024 | 6.841 |
| April 19, 2024 | 6.715 |
| April 18, 2024 | 6.850 |
| April 17, 2024 | 7.098 |
| April 16, 2024 | 7.286 |
| April 15, 2024 | 7.517 |
| April 12, 2024 | 7.693 |
| April 11, 2024 | 7.997 |
| April 10, 2024 | 8.066 |
| April 09, 2024 | 8.193 |
| April 08, 2024 | 7.966 |
| April 05, 2024 | 7.985 |
| April 04, 2024 | 8.016 |
| April 03, 2024 | 8.196 |
| April 02, 2024 | 8.203 |
| April 01, 2024 | 8.318 |
| March 28, 2024 | 8.154 |
| Date | Value |
|---|---|
| March 27, 2024 | 8.276 |
| March 26, 2024 | 8.126 |
| March 25, 2024 | 8.237 |
| March 22, 2024 | 8.452 |
| March 21, 2024 | 8.466 |
| March 20, 2024 | 8.726 |
| March 19, 2024 | 9.132 |
| March 18, 2024 | 9.400 |
| March 15, 2024 | 9.306 |
| March 14, 2024 | 9.610 |
| March 13, 2024 | 9.887 |
| March 12, 2024 | 9.468 |
| March 11, 2024 | 9.477 |
| March 08, 2024 | 9.195 |
| March 07, 2024 | 9.336 |
| March 06, 2024 | 9.272 |
| March 05, 2024 | 9.254 |
| March 04, 2024 | 9.378 |
| March 01, 2024 | 9.526 |
| February 29, 2024 | 9.472 |
| February 28, 2024 | 9.853 |
| February 27, 2024 | 10.17 |
| February 26, 2024 | 9.740 |
| February 23, 2024 | 9.609 |
| February 22, 2024 | 8.972 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
5.240
Minimum
Mar 04 2021
36.66
Maximum
Oct 11 2021
13.69
Average
11.79
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 5.133 |
| Bristol-Myers Squibb Co | 5.408 |
| 2seventy bio Inc | 0.9566 |
| Exelixis Inc | 2.998 |
| Alnylam Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 28.04 |
| PEG Ratio | -2.684 |
| Price | 45.42 |
| Earnings Yield | -6.47% |
| Market Cap | 8.261B |
| PEGY Ratio | -2.684 |